Mettm4Cpo
Targeted Allele Detail
|
|
| Symbol: |
Mettm4Cpo |
| Name: |
met proto-oncogene, receptor tyrosine kinase; targeted mutation 4, Carola Ponzetta |
| MGI ID: |
MGI:2450964 |
| Synonyms: |
Metgrb2neo+ |
| Gene: |
Met Location: Chr6:17463799-17573979 bp, + strand Genetic Position: Chr6, 7.83 cM, cytoband A2
|
| Alliance: |
Mettm4Cpo page
|
|
|
|
| Allele Type: |
|
Targeted (Humanized sequence) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details: A mutant human cDNA coding for the transmembrane and cytoplasmic domain of the receptor was inserted in-frame into mouse genomic sequences. The cDNA was followed by a floxed neomycin resistance cassette. A fusion protein consisting of the murine extracellular domain fused to the human transmembrane and cytoplasmic domain carrying the mutation Y1358N is produced from this allele.
(J:81793)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Met Mutation: |
81 strains or lines available
|
|
| Original: |
J:81793 Ieraci A, et al., Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15200-5 |
| All: |
1 reference(s) |
|